A Randomized Trial Comparing 3- versus 4-Monthly Cardiac Monitoring in Patients Receiving Trastuzumab-Based Chemotherapy for Early Breast Cancer

Purpose: The optimal frequency for cardiac monitoring of left ventricular ejection fraction (LVEF) in patients receiving trastuzumab-based therapy for early breast cancer (EBC) is unknown. We conducted a randomized controlled trial comparing 3- versus 4-monthly cardiac monitoring. Patients and Metho...

Descripción completa

Detalles Bibliográficos
Autores principales: Dent, Susan, Fergusson, Dean, Aseyev, Olexiy, Stober, Carol, Pond, Gregory, Awan, Arif A., McGee, Sharon F., Ng, Terry L., Simos, Demetrios, Vandermeer, Lisa, Saunders, Deanna, Hilton, John F., Hutton, Brian, Clemons, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8700071/
https://www.ncbi.nlm.nih.gov/pubmed/34940066
http://dx.doi.org/10.3390/curroncol28060427

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8700071/
https://www.ncbi.nlm.nih.gov/pubmed/34940066
http://dx.doi.org/10.3390/curroncol28060427

Ejemplares similares